AAPL352.78-3.49 (-0.98%) ▼|ABBV294.55-0.48 (-0.16%) ▼|ABT107.45-1.07 (-0.99%) ▼|ACN247.70-2.79 (-1.11%) ▼|ADBE246.00+2.92 (+1.20%) ▲|AMAT350.25-20.25 (-5.47%) ▼|AMD504.28-29.78 (-5.58%) ▼|AMGN462.32-3.35 (-0.72%) ▼|AMT190.74-0.90 (-0.47%) ▼|AMZN257.75-8.91 (-3.34%) ▼|AVGO333.40-13.61 (-3.92%) ▼|AXP319.05-1.55 (-0.48%) ▼|BA165.22-6.28 (-3.66%) ▼|BAC50.08-0.94 (-1.84%) ▼|BKNG157.53-2.05 (-1.28%) ▼|BLK1,197.97-24.94 (-2.04%) ▼|BMY62.93-0.50 (-0.79%) ▼|BNY151.69-1.72 (-1.12%) ▼|BRK-B592.85-0.09 (-0.02%) ▼|C121.32-2.69 (-2.17%) ▼|CAT570.49-29.71 (-4.95%) ▼|CL100.99+1.32 (+1.32%) ▲|CMCSA25.60+0.44 (+1.75%) ▲|COF193.22-1.06 (-0.55%) ▼|COP140.52-0.83 (-0.59%) ▼|COST1,113.74+7.53 (+0.68%) ▲|CRM214.83-3.01 (-1.38%) ▼|CSCO94.52-1.12 (-1.17%) ▼|CVS88.59-0.76 (-0.85%) ▼|CVX217.14-2.75 (-1.25%) ▼|DE653.99-19.55 (-2.90%) ▼|DHR229.91-3.11 (-1.33%) ▼|DIS118.70-0.27 (-0.23%) ▼|DUK130.59+1.43 (+1.11%) ▲|EMR160.65-5.73 (-3.44%) ▼|FDX327.65+3.51 (+1.08%) ▲|GD359.69-3.77 (-1.04%) ▼|GE325.18-6.63 (-2.00%) ▼|GEV763.57-39.56 (-4.93%) ▼|GILD167.58-0.50 (-0.30%) ▼|GM83.67-2.33 (-2.71%) ▼|GOOG281.26-11.26 (-3.85%) ▼|GOOGL283.72-12.05 (-4.07%) ▼|GS891.54-25.02 (-2.73%) ▼|HD347.51-1.18 (-0.34%) ▼|HON217.95-4.51 (-2.03%) ▼|IBM242.51-4.62 (-1.87%) ▼|INTC55.47-4.19 (-7.02%) ▼|INTU345.56+3.86 (+1.13%) ▲|ISRG437.75-5.84 (-1.32%) ▼|JNJ282.55-3.20 (-1.12%) ▼|JPM338.21-7.98 (-2.31%) ▼|KO99.48+0.23 (+0.23%) ▲|LIN523.46-2.60 (-0.49%) ▼|LLY1,431.67-11.83 (-0.82%) ▼|LMT585.21-10.83 (-1.82%) ▼|LOW224.93-2.80 (-1.23%) ▼|LRCX210.83-15.09 (-6.68%) ▼|MA661.71+0.52 (+0.08%) ▲|MCD274.67+2.70 (+0.99%) ▲|MDLZ67.54+0.00 (+0.00%) ▲|MDT102.88+0.02 (+0.02%) ▲|META626.41-15.28 (-2.38%) ▼|MMM181.68-1.98 (-1.08%) ▼|MO78.90+0.26 (+0.33%) ▲|MRK144.46-3.30 (-2.23%) ▼|MS185.57-5.08 (-2.66%) ▼|MSFT517.99-5.89 (-1.12%) ▼|MU719.02-59.29 (-7.62%) ▼|NEE85.34+0.22 (+0.26%) ▲|NFLX60.75-1.40 (-2.25%) ▼|NKE38.26+0.27 (+0.71%) ▲|NOW99.37-2.88 (-2.82%) ▼|NVDA156.14-6.71 (-4.12%) ▼|ORCL119.09-6.26 (-4.99%) ▼|PEP146.43+0.99 (+0.68%) ▲|PFE28.86-0.03 (-0.10%) ▼|PG173.02+3.22 (+1.90%) ▲|PLTR160.39-7.60 (-4.52%) ▼|PM196.04-2.92 (-1.47%) ▼|QCOM168.52-3.95 (-2.29%) ▼|RTX194.89-3.69 (-1.86%) ▼|SBUX108.72+2.28 (+2.14%) ▲|SCHW92.94-0.04 (-0.04%) ▼|SO94.64+1.81 (+1.95%) ▲|SPG232.78-0.19 (-0.08%) ▼|T22.36+0.18 (+0.81%) ▲|TMO691.33-8.89 (-1.27%) ▼|TMUS170.01+0.06 (+0.04%) ▲|TSLA379.74-10.48 (-2.69%) ▼|TXN294.21-9.39 (-3.09%) ▼|UBER69.99+0.30 (+0.43%) ▲|UNH412.02+4.56 (+1.12%) ▲|UNP303.71+1.27 (+0.42%) ▲|UPS111.82+1.06 (+0.96%) ▲|USB60.43-0.56 (-0.92%) ▼|V426.46+0.70 (+0.16%) ▲|VZ46.34-0.02 (-0.04%) ▼|WFC84.84-1.21 (-1.41%) ▼|WMT128.41+0.32 (+0.25%) ▲|XOM166.87-2.65 (-1.56%) ▼|AAPL352.78-3.49 (-0.98%) ▼|ABBV294.55-0.48 (-0.16%) ▼|ABT107.45-1.07 (-0.99%) ▼|ACN247.70-2.79 (-1.11%) ▼|ADBE246.00+2.92 (+1.20%) ▲|AMAT350.25-20.25 (-5.47%) ▼|AMD504.28-29.78 (-5.58%) ▼|AMGN462.32-3.35 (-0.72%) ▼|AMT190.74-0.90 (-0.47%) ▼|AMZN257.75-8.91 (-3.34%) ▼|AVGO333.40-13.61 (-3.92%) ▼|AXP319.05-1.55 (-0.48%) ▼|BA165.22-6.28 (-3.66%) ▼|BAC50.08-0.94 (-1.84%) ▼|BKNG157.53-2.05 (-1.28%) ▼|BLK1,197.97-24.94 (-2.04%) ▼|BMY62.93-0.50 (-0.79%) ▼|BNY151.69-1.72 (-1.12%) ▼|BRK-B592.85-0.09 (-0.02%) ▼|C121.32-2.69 (-2.17%) ▼|CAT570.49-29.71 (-4.95%) ▼|CL100.99+1.32 (+1.32%) ▲|CMCSA25.60+0.44 (+1.75%) ▲|COF193.22-1.06 (-0.55%) ▼|COP140.52-0.83 (-0.59%) ▼|COST1,113.74+7.53 (+0.68%) ▲|CRM214.83-3.01 (-1.38%) ▼|CSCO94.52-1.12 (-1.17%) ▼|CVS88.59-0.76 (-0.85%) ▼|CVX217.14-2.75 (-1.25%) ▼|DE653.99-19.55 (-2.90%) ▼|DHR229.91-3.11 (-1.33%) ▼|DIS118.70-0.27 (-0.23%) ▼|DUK130.59+1.43 (+1.11%) ▲|EMR160.65-5.73 (-3.44%) ▼|FDX327.65+3.51 (+1.08%) ▲|GD359.69-3.77 (-1.04%) ▼|GE325.18-6.63 (-2.00%) ▼|GEV763.57-39.56 (-4.93%) ▼|GILD167.58-0.50 (-0.30%) ▼|GM83.67-2.33 (-2.71%) ▼|GOOG281.26-11.26 (-3.85%) ▼|GOOGL283.72-12.05 (-4.07%) ▼|GS891.54-25.02 (-2.73%) ▼|HD347.51-1.18 (-0.34%) ▼|HON217.95-4.51 (-2.03%) ▼|IBM242.51-4.62 (-1.87%) ▼|INTC55.47-4.19 (-7.02%) ▼|INTU345.56+3.86 (+1.13%) ▲|ISRG437.75-5.84 (-1.32%) ▼|JNJ282.55-3.20 (-1.12%) ▼|JPM338.21-7.98 (-2.31%) ▼|KO99.48+0.23 (+0.23%) ▲|LIN523.46-2.60 (-0.49%) ▼|LLY1,431.67-11.83 (-0.82%) ▼|LMT585.21-10.83 (-1.82%) ▼|LOW224.93-2.80 (-1.23%) ▼|LRCX210.83-15.09 (-6.68%) ▼|MA661.71+0.52 (+0.08%) ▲|MCD274.67+2.70 (+0.99%) ▲|MDLZ67.54+0.00 (+0.00%) ▲|MDT102.88+0.02 (+0.02%) ▲|META626.41-15.28 (-2.38%) ▼|MMM181.68-1.98 (-1.08%) ▼|MO78.90+0.26 (+0.33%) ▲|MRK144.46-3.30 (-2.23%) ▼|MS185.57-5.08 (-2.66%) ▼|MSFT517.99-5.89 (-1.12%) ▼|MU719.02-59.29 (-7.62%) ▼|NEE85.34+0.22 (+0.26%) ▲|NFLX60.75-1.40 (-2.25%) ▼|NKE38.26+0.27 (+0.71%) ▲|NOW99.37-2.88 (-2.82%) ▼|NVDA156.14-6.71 (-4.12%) ▼|ORCL119.09-6.26 (-4.99%) ▼|PEP146.43+0.99 (+0.68%) ▲|PFE28.86-0.03 (-0.10%) ▼|PG173.02+3.22 (+1.90%) ▲|PLTR160.39-7.60 (-4.52%) ▼|PM196.04-2.92 (-1.47%) ▼|QCOM168.52-3.95 (-2.29%) ▼|RTX194.89-3.69 (-1.86%) ▼|SBUX108.72+2.28 (+2.14%) ▲|SCHW92.94-0.04 (-0.04%) ▼|SO94.64+1.81 (+1.95%) ▲|SPG232.78-0.19 (-0.08%) ▼|T22.36+0.18 (+0.81%) ▲|TMO691.33-8.89 (-1.27%) ▼|TMUS170.01+0.06 (+0.04%) ▲|TSLA379.74-10.48 (-2.69%) ▼|TXN294.21-9.39 (-3.09%) ▼|UBER69.99+0.30 (+0.43%) ▲|UNH412.02+4.56 (+1.12%) ▲|UNP303.71+1.27 (+0.42%) ▲|UPS111.82+1.06 (+0.96%) ▲|USB60.43-0.56 (-0.92%) ▼|V426.46+0.70 (+0.16%) ▲|VZ46.34-0.02 (-0.04%) ▼|WFC84.84-1.21 (-1.41%) ▼|WMT128.41+0.32 (+0.25%) ▲|XOM166.87-2.65 (-1.56%) ▼|
7.7 C
New York
Tuesday, November 17, 2026

Tag: development

Global Open Banking Market Size to Reach USD 136.13 Billion by 2030, Growing at a 27.60% CAGR: MarkNtel Advisors (Capgemini, Oracle, Global Payments, Tata...

Global Open Banking Market Report Overview: NEW DELHI, June 12, 2025 /PRNewswire/ -- The Global Open Banking Market size is experiencing significant growth, projected to...

Taboola Unveils DeeperDive, a Gen AI Answer Engine Built for the Open Web, Connecting Readers with Unique Publisher Content, Empowering Publishers to Defy Abuse...

Powered by Taboola's "Pulse of the Internet," Gannett I USA TODAY Network First to Deploy Technology in the U.S., The Independent First to Deploy...

Bigbank AS Results for May 2025

May was a stable month for Bigbank – both the loan and deposit portfolios grew at a steady pace, and profitability remained at a solid level.

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, announced today the appointment of Dieter Weinand as Chair of the Board of Directors, effective June 12, 2025. Mr. Weinand is the former Chief Executive Officer of Bayer Pharma AG with more than 25 years of experience as a senior business leader in the pharmaceutical industry. He takes over from Dr. Jeanne Bolger, who served as Chair since 2022 and will remain on the Board as a non-executive independent director.

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease...

BRUSSELS and CAMBRIDGE, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate. In the study, DZP demonstrated significant clinical improvements in disease activity in people living with moderate-to-severe systemic lupus erythematosus (SLE), as measured by the British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) at Week 48, the primary endpoint. Improvements were also seen across additional clinical measures, including fatigue and disease activity/remission. These results were presented at EULAR 2025, the European Alliance of Associations for Rheumatology’s annual meeting, in Barcelona, Spain. The safety and efficacy of DZP in SLE have not been established, and it is not approved for use in SLE by any regulatory authority worldwide. A second Phase 3 trial of dapirolizumab pegol is ongoing with the goal of confirming the results from PHOENYCS GO.

Uniting for Impact: “United Against Dengue” Collaboration Launches to Elevate Education, Advocacy and Support across Asia

Led by The International Federation of Red Cross and Red Crescent Societies and Takeda, the regional collaboration is dedicated to supporting the World Health Organization...

UK leads G7 countries in addressing child sexual violence, but ODA cuts are hurting progress

An assessment of five indicators illuminate how the world’s richest nations are addressing the global crisis of childhood sexual violence, UK leads the way

Canada risks missing out on billions in critical mineral investment without swift policy changes: report

Governments can attract investment, accelerate development, and capture opportunities arising from the global energy transition by sharing financial risks while upholding Indigenous rights and...

AHC Hardwood Group Launches New Website and Brand Identity

ATLANTA, June 12, 2025 /PRNewswire/ -- Atlanta Hardwood Corporation, a leader in the U.S. hardwood industry for more than 70 years, has officially rebranded and...

Philips Future Health Index 2025: Delayed care and lost clinical time call for accelerated AI adoption in APAC

66% of patients surveyed in APAC are experiencing delays in seeing specialist doctor, with an average waiting time of 47 days89% of healthcare professionals...

Coaching seen as key priority for the future workplace, yet more than half of business leaders lack the formal training

Coaching (34%) emerges as one of the top initiatives business leaders foresee their organisation prioritising in the next five years. Majority of business leaders (94%)...

Kelun-Biotech’s Novel CLDN18.2 ADC SKB315 IND in Combination with Tagolizumab Receives NMPA Approval for the First-Line Treatment of Gastric/Gastro-oesophageal Junction Cancer

CHENGDU, China, June 11, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that the Company has received a clinical trial notice...

Intensity Therapeutics, Inc. Announces Pricing of Public Offering

SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the...

Nusano Announces Breakthrough HALEU Program Expected to Produce Up to 350 Metric Tons of Fuel Annually for Advanced Nuclear Reactors

WEST VALLEY CITY, Utah, June 11, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming radioisotope production and enabling next-generation energy solutions, announced today the launch of a High-Assay Low-Enriched Uranium (HALEU) production program to support the need for new, sustainable energy solutions and small modular nuclear reactor (SMR) infrastructure in the United States.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment